# Healthcare SEC Filings Snapshot: Acquisitions, Delistings, and New Agreements as of 2026-06-15

> On June 12, 2026, Rocket Pharmaceuticals disclosed a completed asset acquisition while four healthcare companies, Wellgistics Health, OFA Group, Adagio Medical Holdings, and Celularity, each filed delisting notices; separately, Titan Acquisition Corp., Climb Bio, and Snow Rothschild Acquisition Corp. each entered material definitive agreements the same day.

# Healthcare SEC Filings Snapshot

*As of 2026-06-15. All facts sourced exclusively from 8-K filings submitted to the SEC on 2026-06-12.*

---

## What major transaction did Rocket Pharmaceuticals disclose?

Rocket Pharmaceuticals, Inc. filed an 8-K on 2026-06-12 (Accession No. 0001140361-26-024997) reporting the completion of an acquisition or disposition of assets under Item 2.01, accompanied by a Regulation FD disclosure under Item 7.01. The filing was 182 KB and confirms the transaction closed as of the filing date. No financial terms are confirmed by the filing metadata alone.

**Source:** https://www.sec.gov/Archives/edgar/data/1281895/000114036126024997/0001140361-26-024997-index.htm

---

## Which healthcare companies received delisting notices on 2026-06-12?

Four companies each filed an 8-K on 2026-06-12 disclosing a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard (Item 3.01):

1. **Wellgistics Health, Inc.** (Accession No. 0001493152-26-028464, 208 KB)
2. **OFA Group** (Accession No. 0001493152-26-028456, 237 KB)
3. **Adagio Medical Holdings, Inc.** (Accession No. 0001104659-26-073517, 193 KB)
4. **Celularity Inc.** (Accession No. 0001493152-26-028519, 254 KB)

All four filings indicate the companies received formal notice regarding listing deficiencies or potential transfer of listing as of June 12, 2026. The specific exchange standards cited and any cure periods are not confirmed by filing metadata alone.

**Sources:**
- Wellgistics Health: https://www.sec.gov/Archives/edgar/data/2030763/000149315226028464/0001493152-26-028464-index.htm
- OFA Group: https://www.sec.gov/Archives/edgar/data/2036307/000149315226028456/0001493152-26-028456-index.htm
- Adagio Medical Holdings: https://www.sec.gov/Archives/edgar/data/2006986/000110465926073517/0001104659-26-073517-index.htm
- Celularity: https://www.sec.gov/Archives/edgar/data/1752828/000149315226028519/0001493152-26-028519-index.htm

---

## Which entities entered material definitive agreements on 2026-06-12?

Three entities disclosed entry into material definitive agreements (Item 1.01) on 2026-06-12:

1. **Titan Acquisition Corp.** (Accession No. 0001829126-26-006454, 275 KB): Filed Items 1.01 and 9.01, indicating a new material agreement with supporting financial exhibits.
2. **Climb Bio, Inc.** (Accession No. 0001193125-26-269567, 442 KB): Filed Items 1.01, 8.01, and 9.01, the largest of the three filings, suggesting a material agreement alongside other reportable events.
3. **Snow Rothschild Acquisition Corp.** (Accession No. 0001213900-26-068326, 1 MB): Filed Items 1.01 and 3.02, the last indicating unregistered sales of equity securities in connection with the new agreement.

The specific counterparties, deal values, and agreement terms are not confirmed by filing metadata alone.

**Sources:**
- Titan Acquisition Corp.: https://www.sec.gov/Archives/edgar/data/2009183/000182912626006454/0001829126-26-006454-index.htm
- Climb Bio: https://www.sec.gov/Archives/edgar/data/1768446/000119312526269567/0001193125-26-269567-index.htm
- Snow Rothschild Acquisition Corp.: https://www.sec.gov/Archives/edgar/data/2123475/000121390026068326/0001213900-26-068326-index.htm

---

## What does the concentration of filings on 2026-06-12 signal?

Seven of the eight filings covered here were submitted on the same calendar date, June 12, 2026. Four involved listing compliance concerns, one confirmed a closed transaction, and three disclosed new contractual commitments. This concentration reflects the routine mid-year cadence of SEC disclosure obligations rather than a coordinated market event, based solely on the filing data available.

---

*All statements above are grounded exclusively in SEC 8-K filing metadata as of 2026-06-15. Readers should consult the full filing documents for complete terms and disclosures.*

---
Source: MedFuel Intel (https://www.medfuelintel.com/geo/article/healthcare-sec-filings-snapshot-acquisitions-delistings-and-new-agreements-as-of-2026-06-15). Grounded in primary-source-verified events; verify against SEC, FDA, and ClinicalTrials.gov before any investment decision.